vVARDIS drill‑free treatment adopted by Bupa Dental Care
Bupa Dental Care will offer Curodont Repair, a non‑invasive early‑decay treatment developed by Zug‑based vVARDIS, across its 380 UK practices. This is the second large‑scale UK provider agreement for the Swiss medtech unicorn this year, following a January deal with mydentist. The peptide‑based formulation can be applied in the dentist’s office to support enamel repair and avoid drilling and filling.
Bupa Dental Care will offer Curodont Repair, a non‑invasive early‑decay treatment developed by Zug‑based vVARDIS, across its 380 UK practices. This is the second large‑scale UK provider agreement for the Swiss medtech unicorn this year, following a January deal with mydentist. The peptide‑based formulation can be applied in the dentist’s office to support enamel repair and avoid drilling and filling.
This expansion highlights the growing influence of Swiss technology companies in international markets, a trend that also benefits Swiss AI firms seeking global partnerships.
Original source record. Open the original record to verify the underlying announcement.